The Single Use Bioprocess System Market To Be In Sync With Technology, Reach US$

Posted by Ashish on April 8th, 2021

Growing demand for single-use bioprocess systems due to their advantages of lesser cross-contamination chances provides a strong foothold for their use in the biopharmaceutical industry. Pharmaceutical and biotechnology companies are looking forward to continuous manufacturing of pharma products with optimizing speed and sterility assurance, which is expected to surge demand for single-use bioprocess systems. Use of disposable products for bioprocessing application enhances upstream and downstream processes with better safety, sterility, and reliability. Besides, continuous focus by key players to manufacture high quality and technologically-advanced disposable bioprocess systems is also expected to accelerate market growth.

Increasing investments toward manufacturing plant expansion and rising emphasis on low-cost disposable bioprocess product development by key market players are other major factors expected to aid market growth. The global single-use bioprocess systems market was valued at US$ 4.4 Bn in 2020, and is expected to exhibit a CAGR of close to 20% over the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12142

Companies covered in Single Use Bioprocess System Market Report

  • Thermo Fisher Scientific Inc.
  • Sartorius Stedim Biotech
  • Danaher Corporation
  • Merck Millipore
  • Eppendorf AG
  • Celltainer Biotech B.V.
  • Applikon Biotechnology
  • Cellexus Ltd.
  • Parker Hannifin Corp
  • Mettler-Toledo International, Inc.

Like it? Share it!


Ashish

About the Author

Ashish
Joined: September 12th, 2019
Articles Posted: 582

More by this author